The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1517
March 27, 2017
View Complete Issue         Table of Contents 2019 
Triferic for Iron Replacement
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Triferic for Iron Replacement
March 27, 2017 (Issue: 1517)
The FDA has approved ferric pyrophosphate citrate solution (Triferic – Rockwell Medical) to maintain hemoglobin concentrations in adults with hemodialysis-dependent chronic kidney disease. Triferic is the first iron replacement product that...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Triferic for Iron Replacement
Article code: 1517e
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.